<—->

THE St Raphael Charity Foundation.org

FOR NEW PAGES SCROLL DOWN!
REMEMBER TO SCROLL DOWN TO THE BOTTOM TO SEE ALL THAT PAGES CONTENT!!
USE SCROLLERS ON RIGHT—>

ST RAPHAEL 2024 REPORT ON CANCER STATISTICS

Statistics are from the USCS US AGENCY!

The Facts & Figures OUR annual report provides: Estimated numbers of new cancer cases and deaths in 2023 (In 2023, there was an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.)

In the United States alone, an estimated 1,958,310 new cases of cancer will be diagnosed in 2024 and 609,820 people will die from the disease!

In 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States.

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2024) and mortality data collected by the National Center for Health Statistics!

STAGGERING, JUST UNBELIEVABLE!

PEDIATRIC CANCER REPORT

Each year in the U.S. there are an estimated 16,780 children between the ages of birth and 19 years of age who are diagnosed with cancer. Approximately 1 in 285 children in the U.S. will be diagnosed with cancer before their 20th birthday.
315,600 BY 2050!

DO YOU THINK WE NEED AN ORGANIZATION DEDICATED TO CURING CANCER?

A ramp along a curved wall in the Kiasma Museu, Helsinki, Finland

THE CANCER SAGA CONTINUES

THS HAS JUST BEEN RELEASED; NOVEMBER 15, 2024
A new study led by researchers at the Northwestern Medicine Canning Thoracic Institute and published in the Journal of Clinical Investigation has revealed a connection between COVID-19 infection and cancer regression. The team’s discovery could pave the way for novel cancer treatments.

In an unexpected twist, researchers observed that the RNA from the SARS-CoV-2 virus – responsible for COVID-19 – triggered the development of a unique type of immune cell with anti-cancer properties. These cells, dubbed “inducible nonclassical monocytes (I-NCMs),” were found to attack cancer cells and could potentially be harnessed to treat cancers that are resistant to current therapies. These findings possibly explain the mechanism behind the reported regression of certain cancers following COVID-19 infection.
How the Body’s Response to COVID-19 Could Help Fight Cancer
The researchers discovered that during COVID-19, a special subset of immune cells can be stimulated in the body. This process begins when the RNA from the virus activates certain signals in the immune system. These signals cause the transformation of common monocytes – an ordinary type of white blood cell – into I-NCMs. These newly formed cells have the ability to move into both the blood vessels and the surrounding tissue where tumors grow, something most other immune cells can’t do.

MORE THAN EVER St RAPHAEL HOSPITALS ARE NEEDED TO DELIVER THESE TREATMENTS

HERE IS THE PROGNOSIS FOR THE REPORT

 Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers. Incidence rates increased during 2017-2023 by 0.6%-1% annually for breast, pancreas, and uterine corpus cancers and by 2%-3% annually for prostate, liver (female), kidney, and human papillomavirus-associated oral cancers and for melanoma. Incidence rates also increased by 1%-2% annually for cervical (ages 30-44 years) and colorectal cancers (ages <55 years) in young adults. Colorectal cancer was the fourth-leading cause of cancer death in both men and women younger than 50 years in the late-1990s but is now first in men and second in women. Progress is also hampered by wide persistent cancer disparities; compared to White people, mortality rates are two-fold higher for prostate, stomach and uterine corpus cancers in Black people and for liver, stomach, and kidney cancers in Native American people. Continued national progress will require increased investment in cancer prevention and access to equitable treatment, especially among American Indian and Alaska Native and Black individuals.

PEDIATRIC CANCER
Childhood cancer research is consistently underfunded.

Each day, 47 children are diagnosed with cancer in the United States, which means more than 17,000 children in the U.S. are diagnosed each year.

Cancer is the leading cause of death by disease in American children, resulting in the death of approximately 1,800 kids each year.

There are approximately 500,000 childhood cancer survivors in the United States.

In the United States, 85% of children diagnosed with cancer are alive at least five years after diagnosis; however this does not mean they are cured or free from long-term side effects.

Even those who are cured may suffer long-term side effects as a result of the cancer treatments they received. Children who were treated for cancer are twice as likely to suffer chronic health conditions later in life versus children without a history of cancer.

In 2024, approximately 20 million cancer cases will be newly diagnosed and 9.7 million people will die from the disease worldwide. By 2050, the number of cancer cases is predicted to increase to 35 million based solely on projected population growth.

Will cancer be MEDICALLY cured by 2050?

WE WANT, NEED, AND HOPE YOU WILL JOIN US IN VANQUISHING THIS HORRIBLE DISEASE!!!!!!!!!!!

There is only one CANCER and Disease Curing Protocol LEARN ABOUT IT HERE! GOD’S LOVE !

The global burden of cancer is continuing to grow, and there is currently no cure for any type of cancer. Researchers predict more than 35 million new cancer cases by 2050, marking a 77% increase from 2022.

Because cancer is not just a single disease, it is unlikely that there will ever be a single MEDICAL cure for it. Instead, treatments for individual cancers are likely to evolve, making it possible for more people to achieve medical remission for longer periods of time or even permanently.

In a recent study, researchers found a way to change the physical properties of a specific protein that causes 75% of all human cancer cases.

The researchers say the discovery could pave the way for future medical cancer treatments.

Recently, researchers from the University of California, Riverside have found a new way to change the physical properties of a specific protein known to be the culprit in about 75% of all human cancer cases!!

WE ALSO NEED YOUR DONATION TO ST RAPHAEL CHARITY FOUNDATION!!

To Deliver these Treatments to those who are afflicted!!!

PLEASE MAKE A DONATION HERE!!

White abstract geometric artwork from Dresden, Germany

ST RAPHAEL HOSPITALS, RESEARCH LABORATORIES, RESEARCHERS AND TECHNICIANS ARE DEDICATED!

OUR RESEARCH TEAMS will work 24 hours a day until the Medical cure for Cancers, Nerve Neuropathy, Nerve Myopathy, and Nerve Trauma, and Diabetes is achieved.
ST RAPHAEL RESEARH will enrich the world around us.

Meet Our Team

Our comprehensive suite of professionals CONTRIBUTE to a diverse team of experienced individuals, ranging from renowned PhD’S Teaching professors, PhD’S Researchers, Lab Technicians to imaginative chemical engineers.

LEON RUSSELL a.c.s

Founder & CEO

Rhye Moore

Research Manager

Helga Steiner

Laboratory Manager

Ivan Lawrence

Project Manager

We’ve worked with some of the best Pharmacies and Chemical Laboratories.

Enhance your MEDICAL journey with the St. Raphael Knowledge App.

  • Collaborate with Fellow Medical Practitioners.
  • Showcase your projects.
  • Experience the World of Medicine.

White abstract geometric artwork from Dresden, Germany

St. RAPHAEL CHARITY FOUNDATION

ADDRESS: 1606 OHIO AVENUE
ASHTABULA, OH 44004

PHONE: 440-855-0658

EMAIL: STRAPHAELCHARITYFOUNDATION@GMAIL.COM





s2Member®